What question did this study set out to answer?

To evaluate the effectiveness of the systemic immune-inflammation index as a biomarker for colorectal cancer risk in patients with colonic polyps.

March 22, 2026

Systemic immune-inflammation index may be used to predict the development of colorectal cancer from colonic polyps

Key Points

To evaluate the effectiveness of the systemic immune-inflammation index as a biomarker for colorectal cancer risk in patients with colonic polyps.
Assessment of systemic immune-inflammation index in patients with colonic polyps
Analysis of its correlation with colorectal cancer risk
Systemic immune-inflammation index serves as a noninvasive biomarker for colorectal cancer risk
Higher index values are associated with increased risk of developing colorectal cancer.

Abstract

SII is a promising, noninvasive biomarker for identifying patients at increased risk of CRC among those with colonic polyps. Further prospective studies are needed to confirm these findings.

Systemic immune-inflammation index may be used to predict the development of colorectal cancer from colonic polyps

Key Points

Abstract

Cite This Study

Also Consider

Also Consider